Zensar acquires BridgeView Life Sciences to enhance its LHS offerings

Zensar Technologies announced today the full acquisition of BridgeView Life Sciences LLC. The US]based leader in information technology and operations provides a comprehensive range of advisory, transformation, and managed services exclusively for life sciences customers endeavoring to launch products or new indications, assess and optimize their operations, or engage in merger or acquisition transactions. This strategic move strengthens Zensar's Healthcare and Life Sciences (HLS) vertical and expands its pharma commercial and product launch expertise.